Table 2.
Tools to study NHPs as related to the immune system
| Experimental models/tools | Pros | Cons |
|---|---|---|
| In vitro measurement on cell culture | Can target specific effects of the studied product on specific cell types | Simplistic model, systemic effects not taken into consideration |
| Very helpful for investigating cellular and molecular mechanisms | NHP administration generally not physiological | |
| Large number of very well characterized systems with efficient markers of activation/inhibition | ||
| Genomics/proteomics | New analytical tools | Cost of utilization |
| Very precise results | Availability of source material | |
| Can be used in fundamental research as well as clinical trials | ||
| Animal models | Mouse has a very well characterized genome | Despite high similarities with man, uncertainty whether mice and men react the same way |
| Complete living organism | Difficulty in measuring environmental components on a mouse | |
| Genetically modifiable (transgenic and knock out mice) | ||
| Large number of well characterized models for several human pathologies | ||
| Clinical trials | Gold standard for safety and efficacy | Weakness or lack of proper markers to evaluate success of intervention |
| Direct and systemic effects measured on health | Improper administration/standardization of NHPs | |
| Epidemiological studies | Large-scale studies on the population | Challenge in scientifically measuring dietary exposure in the population |
| Can include both the environmental and germ line components of disease | Large cohorts needed for significant conclusions |